September 2026
The global in vivo cell reprogramming market is expanding as regenerative medicine advances toward direct in-body cell conversion for tissue repair and disease treatment.
September 2026
The global cell banking outsourcing market size was evaluated at USD 17.95 billion in 2026 and is projected to reach around USD 48.17 billion by 2035, with a CAGR of 11.6%.
September 2026
The global cell cycle inhibitors market size was evaluated at USD 6.13 billion in 2026 and is predicted to hit around USD 11.50 billion by 2035, growing at a CAGR of 7.23%.
September 2026
The printable solar cells market size is calculated at USD 36.12 billion in 2026 and is projected to hit around USD 54.04 billion by 2035 with a CAGR of 4.58%.
September 2026
The global single cell analysis market size is expected to increase from USD 5.59 billion in 2026 and is expected to hit around USD 20.69 billion by 2035, growing at a CAGR of 15.78%.
September 2026
The global image-based cytometry in cell analysis market size is accounted to hit around USD 9.78 billion by 2035 increasing from USD 4.06 billion in 2026, with a CAGR of 10.27%.
September 2026
The global engineered T cells market size is worth at USD 63.16 billion in 2026 and is expected to hit over USD 769.84 billion by 2035 with a CAGR of 32.12%.
September 2026
The global single-cell genomics market is growing as advanced sequencing technologies enable high-resolution analysis of individual cells.
September 2026
The cellular vehicle-to-everything (C-V2X) market reached USD 2.22 billion in 2026, with prominent companies such as Qualcomm Technologies Inc., Huawei Technologies Co., Ltd., Intel Corporation leading the cellular vehicle-to-everything (C-V2X) market.
September 2026
The cell-free protein expression market size is expected to increase from USD 313.88 million 2026 and is expected to hit around USD 585.10 million by 2034 with a CAGR of 8.07%.
September 2026
The global single cell sequencing market size is estimated to hit around USD 11.09 billion by 2035, increasing from USD 3.24 billion in 2026, with a CAGR of 14.67%.
September 2026
The global thin film solar cell market size is calculated at USD 16.81 billion in 2026 and is projected to hit around USD 32.06 billion by 2034 with a CAGR of 8.40%.
September 2026
The global stem cell banking market size was valued at USD 8.93 billion in 2026 and is expected to surpass around USD 27.71 billion by 2034 with a CAGR of 15.29%.
September 2026
The cell penetrating peptide market size was estimated at USD 2.88 billion in 2026 and is expected to hit around USD 9.95 billion by 2035, growing at a CAGR of 14.9%.
September 2026
The global live cell imaging market size is calculated at USD 3.56 billion in 2026 and is projected to hit around USD 7.22 billion by 2035 with a CAGR of 8.21%.
September 2026
The global monocrystalline solar cell market size is estimated at USD 7.71 billion in 2026 and is projected to hit around USD 15.92 billion by 2035 with a CAGR of 8.39%.
September 2026
The polycrystalline solar cell market size was valued at USD 4.04 billion in 2026 and is projected to hit around USD 7.01 billion by 2034 with a CAGR of 7.10%.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global in vivo CRO market size is estimated to hit around USD 11.7 billion by 2035, increasing from USD 5.84 billion in 2026, with a CAGR of 8.11%.
September 2026
The global stem cell manufacturing market size reached USD 17.57 billion in 2026 and is projected to surpass around USD 45.38 billion by 2035, with a solid CAGR of 11.13%.
September 2026
The global microcrystalline cellulose (MCC) market size is predicted to surge around USD 2.92 billion by 2035 from USD 1.59 billion by 2026, with a solid CAGR of 6.96%.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The global large-scale active stem cell clinical trials market size was evaluated at USD 8.27 billion in 2026 and is predicted to hit around USD 28.88 billion by 2035, growing at a CAGR of 14.90%.
September 2026
The global in vivo CAR-T therapy market size was evaluated at USD 861.25 million in 2026 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The global induced pluripotent stem cells market size is estimated to hit around USD 5.57 billion by 2035, increasing from USD 2.13 billion in 2025, with a CAGR of 10.09%.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The global single-cell omics market size is projected to hit around USD 45.28 billion by 2035 from USD 6.19 billion in 2025 with a CAGR of 22.02%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com